This theory should explain the apparent paradox of a ubiquitous factor B-MYB-being upstream of a tissue specific factor –MYCN- and clarify why MYCN is not activated in the vast cohort of non-neuronal tumours where B-MYB is overexpressed or amplified. This evidence concerns the gene MYBL2 and neoplasm.